This inventor holds 2 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Toyama Chemical Co., Ltd.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Namika Nakamatsu: Innovator in Pharmaceutical Chemistry
Introduction
Namika Nakamatsu is a notable inventor based in Toyama, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with enhanced solubility for injection preparations. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.
Latest Patents
Nakamatsu's latest patents include the "Sodium salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide." This preparation is characterized by its superior solubility, making it useful as an injectable formulation. Another significant patent is the "Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide," which also boasts enhanced solubility and is intended for injection use. These innovations reflect his commitment to improving pharmaceutical formulations.
Career Highlights
Nakamatsu is currently associated with Toyama Chemical Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention for its practical applications in the pharmaceutical industry, contributing to the development of more effective medications.
Collaborations
Nakamatsu collaborates with talented colleagues, including Keiko Takakura and Sakiko Takeshima. Their combined expertise fosters a productive environment for innovation and research.
Conclusion
Namika Nakamatsu's contributions to pharmaceutical chemistry through his patents demonstrate his dedication to enhancing medical treatments. His work continues to influence the field positively, paving the way for future advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile